Jennifer Jao, MD, MPH

Research Interests

  • HIV/AIDS
  • Maternal-Child HIV
  • Pregnancy
  • Metabolic Complications of HIV and its Treatment
  • Women’s Health
  • Pediatric, Adolescent HIV

Biography

  • Attending Physician, Infectious Disease, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Associate Professor of Pediatrics (Infectious Diseases), Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Dual certified in Internal Medicine and Pediatrics, Jennifer Jao, MD, MPH, is an Associate Professor in the Departments of Pediatric and Adult Infectious Diseases at Northwestern University Feinberg School of Medicine. She is a member of the U.S. Panel on the Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission Guidelines Panel; Co-Chair of the International Maternal Pediatric Adolescent AIDS Clinical Trials network P1115 Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission protocol; and Co-Chair of the Nutrition, Growth, and Metabolic Working Group in the Pediatric HIV/AIDS Cohort Study. Dr. Jao leads multiple NIH-funded pediatric and maternal-pediatric HIV cohorts both in the United States and Africa. As a translational researcher, Dr. Jao targets her research portfolio to the long-term metabolic effects of HIV and antiretroviral therapy. 

Education and Background

  • Infectious Disease Fellowship, Icahn School of Medicine at Mount Sinai 2010
  • MPH, Icahn School of Medicine at Mount Sinai 2010
  • Internal Medicine and Pediatrics Residency, Rush University Medical Center 2002
  • MD, Medical College of Georgia 1998

Featured Grants

ORCHID—Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir

National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development
09/25/2020 → 06/01/2025

Understanding Inflammatory and Metabolic Pathways of Myocardial and Vascular Dysfunction in South African Youth Living with Perinatal HIV

National Institutes of Health/National Heart, Lung, and Blood Institute
05/01/2020 → 04/01/2025

The Tshilo Dikotla Study: Metabolic Outcomes of Children HIV/ARV-exposed Uninfected in Botswana

National Institute of Diabetes and Digestive and Kidney Diseases
04/18/2017 → 03/31/2022

Pediatric HIV/AIDS Cohort Study (PHACS)

National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development
09/01/2020 → 07/31/2025

FLOURISH—Following Longitudinal Outcomes to Understand, Report, Intervene and Sustain Health of Infants, Children and Adolescents who are HIV Exposed Uninfected

National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development
08/17/2020 → 06/30/2022

IMPAACT Leadership Group—P1115 Protocol: Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission: A Phase I/II Proof of Concept Study

National Institutes of Health/National Institute of Allergy and Infectious Diseases
12/01/2020 → 11/30/2026

Similar Researchers

Clinical and Community Trials

Research Interests

Critical Care, Viral Respiratory Infections, Lung Injury and Repair, Immune Regulation

Recent Publication

Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2.

Clinical and Community Trials

Research Interests

Interventricular Mechanics, Right Ventricular Failure, Role of Immunologic Phenotype on Post-heart Transplant Outcomes, Post-heart Transplant Kidney Injury and Failure

Clinical and Community Trials